Build Your Regenerative Medicine Authority Regenerative medicine authority starts with smart plans. Plus, you need strong leaders. Also, you must help patients. Therefore, this takes real work. The field needs great leaders today. Moreover, these leaders mix science with business. Thus, they help change patient care. Meanwhile, data proves the methods work. In fact, they
The ISSCA Conference 2025 is redefining global regenerative medicine. Starting with its successful edition in Cancun, Mexico on September 13–14, the event set new clinical and compliance standards for stem cell therapy, exosomes, and cellular applications. The journey continues in São Paulo, Brazil, on October 2–3, bringing even more training, certification, and collaboration opportunities. Highlights
Regenerative medicine breakthroughs are reshaping healthcare. Once seen as experimental, these therapies are now entering clinical practice. The question has shifted from “Do they belong in medicine?” to “How do we use them best?” From Research to Clinical Care The shift from lab research to standard care requires structure. Doctors must track patient outcomes and
Despite progress in cardiovascular research, cardiac pathology continues to be one of the most common causes of morbidity and mortality in the world. Stem cell-based therapy has been recognized as an innovative strategy for the repair, regeneration and functional recovery of the myocardium, hence, once the animal research stage has been overcome, most clinical trials
Atherosclerosis is the most common form of arterial occlusive disease in adults. About 15 percent of adults over 55 years of age suffer from critical ischemia, the most severe form of this disease. Due to the gradual aging of the population and the growing number of people in their third age group, a number of
In recent years, MSCs have been introduced as respectable candidates for regenerative medicine due to their pro-angiogenic, anti-apoptotic, and immunomodulatory attributes. A variety of human tissues can be used as a source of mesenchymal stem/stromal cells (MSCs), ranging from bone marrow (BM) to umbilical cord (UC). These cells are typically multipotent and can differentiate into
Osteoarthritis is a rheumatic pathology that damages the articular cartilage. By joining two bones through the joint capsule, the joints are able to move, providing us with functional autonomy. An inner fluid called synovial fluid is usually found within joints, which is produced by the synovial membrane. Articular cartilage covers the ends of the bones
Stem cell therapy is a form of regenerative medicine designed to repair damaged cells within the body by reducing inflammation and modulating the immune system. This phenomenon makes stem cell therapy a viable treatment option for a variety of medical conditions. What is stem cell therapy? The term stem cell therapy refers to any treatment
Exosomes are potent microvesicles released by adult mesenchymal stem cells. They have the ability to help restore cells in the body by improving cell to cell communication. Exosomes are not cells, and they are smaller than cells. When compared to adult stem cells, exosomes have much more growth factors which give them a better clinical
In recent years, the application of exosomes in regenerative medicine has been growing. Also, many more potential applications of exosomes in regenerative medicine are still being studied. In this article, you’ll learn the functions of exosomes and up-to-date applications of exosomes in regenerative medicine. What are exosomes? Exosomes are tiny vesicles that play a crucial